Mayne Pharma GroupMYX 
$3.132.89%24h
2.89%24h
Global rank15467
Market cap$257.41M
Change 7d-8.68%
YTD Performance-24.72%
SP500 benchmarkUnderperform
P/E0
P/S2.09
Revenue$123.39M
Earnings$79.26M
Dividend yield-
Main Sector
Healthcare
Category
Mayne Pharma Group (MYX) Net Assets
MYX Net Assets in 2023: $634.36M
As of 4 Nov 2024, Mayne Pharma Group net assets is $634.36M, an increase of 13.86% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Mayne Pharma Group overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Mayne Pharma Group Net Assets History from 2019 to 2024
-
Value:-
MYX Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $634.36M | 13.86% |
| 2022 | $557.12M | -27.79% |
| 2021 | $771.58M | -25.97% |
| 2020 | $1.04B | 3.43% |
| 2019 | $1.01B | - |
View the Top Net Assets Companies
